Publications
2018
  • Visante Insider – October 2018

    In this edition of the Visante Insider:

    Case Study: 340B Covered Entity Overcomes Challenges of Disparate Split-Billing Systems
    8 Commonly Overlooked Areas of USP Compliance May Cause Major Problems
    On the Road to USP 800 Compliance: Section 13 – Compounding
    
  • Hospital Leadership Support Critical for 340B Compliance

    James Jorgenson

    Visante CEO, James Jorgenson recently put together a list of 6 questions that should be on the minds of hospitals that want to make their 340B Programs successful now and in the future.

    Read the full article here.

  • Visante Insider – September 2018

    In this edition of the Visante Insider:

    On the Road to USP 800 Compliance Section 12 - Dispensing Final Dosage Forms
    6 questions you need to ask hospital leadership re: 340B Program
    Preventing drug diversion continues to challenge US hospitals
    PCMA research shows PBMs are part of the solution to high drug prices
    Don't miss the excellent 340B webinar on contract pharmacies
    
  • Choosing Proper Hazardous Drug PPE for USP <800>: Part 1

    Fred Massoomi
    Journal Citation: Pharmacy Purchasing & Products, June 2018, Vol.15 No.6 – page 24

    Choosing proper personal protective equipment (PPE) is fundamental to minimize risk of exposure to hazardous drugs. Also critical is the correct donning, doffing and disposal of gloves, gowns, shoe covers and sleeve covers. Our expert Fred Massoomi, PharmD, FASHP explains in this recent PP&P article.

    Read the full article here.

  • Visante Insider – August 2018

    In this edition of the Visante Insider:

    Best practices for ensuring 340B Program Integrity
    On the Road to USP &lt;800&gt; Compliance: Section 11
    Joint Commission announces enhanced surveys for sterile compounding
    Choosing Proper Hazardous Drug PPE for USP &lt;800&gt;: Part 1
    
  • Pharmacists, It’s Time to Speak Up

    James Jorgenson
    Journal Citation: Drug Topics, Vol. 162, Issue 7

    In the July edition of Drug Topics, James Jorgenson, CEO, explains the importance of transformational change and why it is needed to achieve breakthrough results in U.S. healthcare. A major opportunity for innovative thinking includes how pharmacy is positioned in the healthcare system.

    Read the full article here.